Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HeraMED Ltd. ( (AU:HMD) ) has issued an announcement.
HeraMED Limited announced an upcoming investor update webinar to discuss recent partnerships with Royal Philips and a pilot launch with Lee Health. The webinar will feature discussions on the company’s recent activities and future outlook, providing stakeholders an opportunity to engage with the leadership team.
More about HeraMED Ltd.
HeraMED Limited is a medical data and technology company focused on transforming maternity care through digital solutions. The company offers a hybrid maternity care platform that integrates hardware and software, including the HeraBEAT monitor and HeraCARE ecosystem, to enhance prenatal and postpartum experiences. Their solutions aim to improve maternal health care by providing better care at lower costs, engaging expectant mothers, and enabling healthcare professionals to deliver high-quality care with early risk detection.
Average Trading Volume: 1,632,874
Technical Sentiment Signal: Buy
Current Market Cap: A$43.81M
For a thorough assessment of HMD stock, go to TipRanks’ Stock Analysis page.